» Articles » PMID: 22228091

Risk Factors for Distal Contegra Stenosis: Results of a Prospective European Multicentre Study

Overview
Date 2012 Jan 10
PMID 22228091
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives The EUCon study was designed to identify risk factors for distal anastomotic stenosis after bovine jugular vein (Contegra) implantation in children. Methods Between March 2006 and August 2008, 104 devices were implanted in nine European centers. Preoperative, intraoperative, and follow-up data (at discharge, 6, 12, 24 months) including standardized echocardiography were prospectively registered, source data verified and collected in a central database. Main endpoint was distal stenosis (either postvalvular gradient of ≥50 mm Hg or need for intervention for distal stenosis). Eight potential risk factors (age <2 years, diagnosis, running suture, use of glue, flapless anastomosis, oversizing less than + 2 z, anticoagulation, implantation site) were investigated. Cox regression, decision tree analyses, and "Clustering by Response" were applied. Results Patient age ranged from 0 to18 years, mean 6.0 ± 6.1, median 3.2 years. Implantation reasons: 88% congenital malformations, 12% Ross operations. Follow-up was 88.3% complete. Durability (freedom from death, reoperation, degeneration, endocarditis, and explantation) compared well to corresponding homograft literature. Sixteen patients reached study endpoints. Age <2 years was the only invariably significant risk factor (p = 0.044); "Clustering By Response" found young anticoagulated patients with oversized conduits to be at a higher risk than the others (p = 0.018, OR = 3.2). Conclusion Patient age is the main risk factor for development of distal anastomosis stenosis after Contegra implantation. The influence of the other investigated factors is too small to be proven in 104 patients after 2 years, or other risk factors must be taken into consideration to explain outcome differences among recipients under 2 years.

Citing Articles

Matched comparison of decellularized homografts and bovine jugular vein conduits for pulmonary valve replacement in congenital heart disease.

Bobylev D, Horke A, Avsar M, Cvitkovic T, Boethig D, Hazekamp M Cell Tissue Bank. 2023; 25(1):55-66.

PMID: 36917328 PMC: 10901942. DOI: 10.1007/s10561-023-10082-4.


Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.

Li C, Xie B, Tan R, Liang L, Peng Z, Chen Q Front Bioeng Biotechnol. 2022; 10:920152.

PMID: 35992331 PMC: 9386425. DOI: 10.3389/fbioe.2022.920152.


Midterm Outcomes of Crosslinked Acellular Bovine Jugular Vein Conduit for Right Ventricular Outflow Tract Reconstruction.

Qian T, Wu Z, Hu J, Yang Y, Wu Q, Lu T Front Pediatr. 2021; 9:725030.

PMID: 34485205 PMC: 8416030. DOI: 10.3389/fped.2021.725030.


Mid-term outcomes of Contegra implantation for the reconstruction of the right ventricular outflow tract to proximal branch pulmonary arteries: Japan multicentre study.

Hoashi T, Ichikawa H, Hirose K, Horio N, Sakurai T, Matsuhisa H Interact Cardiovasc Thorac Surg. 2021; 33(2):227-236.

PMID: 33755119 PMC: 8691546. DOI: 10.1093/icvts/ivab075.


Outcomes of Prosthetic Valved Conduits for Right Ventricular Outflow Tract Reconstruction.

Chen H, Shi G, Qiu L, Wang S, Chen H, Xu Z Pediatr Cardiol. 2019; 40(4):848-856.

PMID: 30887063 DOI: 10.1007/s00246-019-02081-8.